|
- Agenda -
The agenda is also available as download (PDF)
Details about the juried Posters are available
here (PDF)
Details about the 'Late Breaker' Posters are
available here (PDF)
Saturday, May 30, 2009
Welcome
Antonino Catanzaro MD. University of
California San Diego, USA
Giovanni Migliori MD. WHO Collaborating Center for TB and Lung
Diseases, Italy
Luca Richeldi MD PhD. University of Modena and Reggio Emillia,
Italy
Session 1 - Biology of Tuberculosis: Busting Dogmas
Keynote Address I
Shreemanta Parida MD., PhD, Max Planck Institute
for Infection Biology, Germany
"Closing the gaps in our understanding of
the pathogenesis of tuberculosis"
Keynote Address II
David Lewinsohn MD PhD, Oregon Health and Science University, USA
"Natural history of TB"
Coffee Break
Selected Abstracts
Morten Ruhwald, J. Peterson, K. Kofoed, H. Nakaoka, L. Cuevas, L. Lawson, S. Squire, J. Eugen-Olsen, P. Ravn
"Improving T-cell assays for the diagnosis of active and latent TB infection using IP-10"
Novel Chegou, G. Black, P. van Helden, G. Walzl
"Differentiate active TB from latent TB infection: preliminary report"
Delia Goletti, O. Butera, V. Vanini, T. Ottenhof, E. Girardi
"New tools to discriminate active tuberculosis disease from LTBI"
Cynthia Chee, K. KhinMar, S. Gan, T. Barkham, C. Koh, Y. Wang
"Use of QuantiFERON-TB Gold in monitoring treatment"
Madhukar Pai, R. Joshi, D. Gajalakshmi, M. Reddy, S. Kalantry
"Unstable IGRA conversions and revisions in a high-incidence setting"
Richard van Zyl-Smit, R. Meldau, G. Symons, H. Khalfey, S. Meldau, M. Badri, L. Sechi, R. Dawson, E. Bateman, A. Zumla, K. Dheda
"Antigen-specific alveolar-lymphocyte IFN-gamma responses for the rapid diagnosis of pulmonary tuberculosis"
Alice Zwerling, J Ladurantaye, D Menzies, M Pai
"T-cell IFN-gamma responses in patients treated for LTBI"
Juried Poster viewing
Closing Comments
Ajit Lalvani MA MBSS DM FRCO, Imperial College, UK
"Future Directions"
Tony Radford DCM BSc (Hons) PhD., Cellestis, Australia
"Welcome from Cellestis"
Sunday, May 31, 2009
Session 2 - Contact Tracing and Outbreak
Nobuyuki Harada PhD, The Research Institute of Tuberculosis, Japan
"The impacts of IGRAs on contact tracings—Japanese experiences"
Albert Nienhaus MD PhD MPH, Accident Insurance
for the Healthcare sector, Germany
"Benefits of introducing IGRAs into contact tracings—a German perspective"
Discussion
Session 3 - IGRAs in HCW
Toru Mori MD PhD, Research Institute of Tuberculosis, Japan
"QuantiFERON-TB Gold in HCW screening in BCG vaccinated population"
Charles Daley MD, National Jewish Health, USA
"Comparison of IGRAs in HCW screening in the USA"
Discussion
Coffee Break
Selected Abstracts
Lesley Scott, P Fakir, K McCarthy, T Mosendane, A van Rie, F Venter, W Stevens
"QuantiFERON-TB Gold values around the cut-off—what do they mean?"
Alice Zwerling, M Behr, A Verma, T Brewer, D Menzies, M Pai
"Findings from the World BCG Atlas—countries likely to benefit from the highly specific IGRAs"
Session 4 - IGRAs in Vulnerable Populations
Luca Richeldi MD PhD, University of Modena and Reggio Emillia, Italy
"IGRAs in the Face of Comorbid Conditions"
Pernille Ravn MD PhD, University Hvidovre Hospital, Denmark
"The usefulness of IGRAs in the presence of
HIV"
Discussion
Lunch
Selected Abstracts
Bolette Søborg, M Ruhwald, M Hetland, S Jacobsen, A Andersen, N Milman, V Thomsen, D Jensen, A Koch, J Wohlfahrt, P Ravn
"Comparison of screening procedures for LTBI among patients with inflammatory diseases"
Filippo Bartalesi, D Goletti, A Cavallo, L Attala, G Fiori, F Li Gobbi, A Mantella, M Benucci, M Matucci Cerinic, E Girardi, A Bartoloni
"LTBI treatment in subjects with autoimmune diseases and T-cell interferon-gamma responses"
Dario Ponce de Leon, E Acevedo, S Alvizuri
"Comparison of IGRAs with TST for the detection of LTBI in RA patients in a TB endemic population"
Session 5 - Applications of IGRAs
Masae Kawamura MD, San Francisco Dept of Public Health, USA
"Overcoming obstacles to successful applications of IGRAs"
Ibrahim Abubakar MBBS MPH. Health Protection Agency, UK
"Implementing IGRAs in the UK—constraints and opportunities"
Discussion
Coffee break
Session 6 - Longitudinal Studies-PPV and NPV of IGRAs
Hassan Mahomed MD, University of Cape Town, South Africa
"Predictive value of TST vs QFT in adolescents in a high burden setting"
Maximilian Aichelburg Vienna Medical School, Austria
"Progression in HIV positive"
Roland Diel MD PhD, University of Duesseldorf, Germany
"Predictive value of Interferon-gamma Release Assays—a snapshot June 2009"
Selected Abstracts
Sandra Kik, W Franken, M Mensen, M Kamphorst-Roemer, F Cobelens, S Arend, M Borgdorff, S Verver
"Predicting tuberculosis by IGRA among foreign-born contacts"
Discussion
Symposium Dinner and Presentation
Richard O’Brien MD, FIND, Switzerland
"Introduction"
John Sbarbaro MD MPH FCCP. University of Colorado Health Sciences Center, USA
"Is there a role for TST?"
Monday, June 1, 2009
Session 7 - IGRAs in children
Deborah Lewinsohn MD. Oregon Health and Science University, USA
"IGRAs in children"
Selected Abstracts
Kazue Higuchi, S Kondo, M Wada, S Hayashi, G Ootsuka, N Sakamoto, N Harada
"Contact investigation in a primary school using IGRAs"
Discussion
Session 8 - Economic Issues
Akiko Kowada MD PhD. Katsushika City Public Health Centre, Japan
"Cost effectiveness of IGRAs in Japan"
Masae Kawamura MD. San Francisco Dept of Public Health, USA
"Tuberculosis screening of contacts and HCWs in San Francisco"
Discussion
Coffee Break
Session 9 - Guidelines
Madhukar Pai, MD PhD, McGill University, Canada
"Guidelines on IGRAs: concordant or discordant?"
Kenneth Castro MD. Centers for Disease Control and Prevention, USA
Jean-Pierre Zellweger MD. University of Lausanne, Switzerland
Roland Diel MD PhD. University of Dusseldorf, Germany
Madhukar Pai MD PhD. McGill University, Canada
Toru Mori MD PhD. Research Institute of Tuberculosis, Japan
Luca Richeldi MD PhD. University of Modena and Reggio Emilia, Italy
"Panel discussion of guidelines of various countries"
Christian Lienhardt MD PhD. WHO, Switzerland
"A global perspective of how IGRAs can be used"
Closing Remarks
Antonino Catanzaro MD. University of California San Diego, USA
Luca Richeldi MD PhD. University of Modena and Reggio Emilia, Italy
Lunch
|
